Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan J Mattison

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Clinical Advances in Hematology & Oncology : H&O|August 2, 2018
A closer look at blinatumomabRyan J Mattison
Current Opinion in Oncology|August 29, 2009
Role of allogeneic hematopoietic cell transplantation in adults with acute lymphoblastic leukemiaRyan J Mattison, Richard A Larson
Current Opinion in Hematology|January 19, 2013
New strategies for the evaluation of the nadir bone marrow following induction in acute myeloid leukemiaRyan J Mattison, Selina M Luger, Hillard M Lazarus
Leukemia & Lymphoma|April 14, 2016
Management of differentiation syndrome in an elderly patient with acute promyelocytic leukemia who subsequently developed refractory anemia with ring sideroblastsRyan A Denu, Rodolfo Henrich Lobo, Ryan J Mattison
Leukemia & Lymphoma|December 6, 2021
Clinical utility and real-world application of molecular genetic sequencing in the management of patients with acute myeloid leukemia and myelodysplastic syndromesLauren G Banaszak, Erica Reinig, Michael R Lasarev, et al.
Reviews on Recent Clinical Trials|May 14, 2008
Implications of FLT3 mutations in the therapy of acute myeloid leukemiaRyan J Mattison, Kelly R Ostler, Frederick L Locke, et al.
Journal of Cutaneous Pathology|February 17, 2024
Histopathologic evidence of chimeric antigen receptor T-cell therapy in lesions of B-cell lymphoblastic leukemia cutisAman Nihal, Jeanette R Comstock, Daniel D Bennett, et al.
Leukemia Research|June 1, 2023
Neighborhood disadvantage, insurance status, and molecular profiling of patients with acute myeloid leukemiaRory Bade, Lauren G Banaszak, Fauzia Osman, et al.
International Journal of Hematologic Oncology|November 29, 2021
A Phase I trial of talazoparib in patients with advanced hematologic malignanciesAjay K Gopal, Rakesh Popat, Ryan J Mattison, et al.
Genes, Chromosomes & Cancer|June 20, 2020
Chromosomal instability upregulates interferon in acute myeloid leukemiaNing Jin, Robert F Lera, Rachel E Yan, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Clinical Advances in Hematology & Oncology : H&O|August 2, 2018
A closer look at blinatumomabRyan J Mattison
Current Opinion in Oncology|August 29, 2009
Role of allogeneic hematopoietic cell transplantation in adults with acute lymphoblastic leukemiaRyan J Mattison, Richard A Larson
Current Opinion in Hematology|January 19, 2013
New strategies for the evaluation of the nadir bone marrow following induction in acute myeloid leukemiaRyan J Mattison, Selina M Luger, Hillard M Lazarus
Leukemia & Lymphoma|April 14, 2016
Management of differentiation syndrome in an elderly patient with acute promyelocytic leukemia who subsequently developed refractory anemia with ring sideroblastsRyan A Denu, Rodolfo Henrich Lobo, Ryan J Mattison
Leukemia & Lymphoma|December 6, 2021
Clinical utility and real-world application of molecular genetic sequencing in the management of patients with acute myeloid leukemia and myelodysplastic syndromesLauren G Banaszak, Erica Reinig, Michael R Lasarev, et al.
Reviews on Recent Clinical Trials|May 14, 2008
Implications of FLT3 mutations in the therapy of acute myeloid leukemiaRyan J Mattison, Kelly R Ostler, Frederick L Locke, et al.
Journal of Cutaneous Pathology|February 17, 2024
Histopathologic evidence of chimeric antigen receptor T-cell therapy in lesions of B-cell lymphoblastic leukemia cutisAman Nihal, Jeanette R Comstock, Daniel D Bennett, et al.
Leukemia Research|June 1, 2023
Neighborhood disadvantage, insurance status, and molecular profiling of patients with acute myeloid leukemiaRory Bade, Lauren G Banaszak, Fauzia Osman, et al.
International Journal of Hematologic Oncology|November 29, 2021
A Phase I trial of talazoparib in patients with advanced hematologic malignanciesAjay K Gopal, Rakesh Popat, Ryan J Mattison, et al.
Genes, Chromosomes & Cancer|June 20, 2020
Chromosomal instability upregulates interferon in acute myeloid leukemiaNing Jin, Robert F Lera, Rachel E Yan, et al.
Pageof 4